ARK & TLK Investments’s Checkpoint Therapeutics CKPT Stock Holding History

ARK & TLK Investments’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$40.4K	–	117
2025 Q1	$40.4K	Hold	10,000	–	–	0.01%	112
2024 Q4	$32K	Hold	10,000	–	–	0.01%	111
2024 Q3	$22.4K	Hold	10,000	–	–	0.01%	108
2024 Q2	$21.5K	Hold	10,000	–	–	0.01%	106
2024 Q1	$20.5K	Hold	10,000	–	–	0.01%	105
2023 Q4	$22.9K	Buy	+10,000	New	+$21.8K	0.01%	110

ARK & TLK Investments's CKPT Position: Q2 2025 in Review

ARK & TLK Investments sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 10,000 shares — an estimated $40.4K sold.

ARK & TLK Investments first reported a position in CKPT in Q4 2023 and held it in 6 quarters. The position peaked at $40.4K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

ARK & TLK Investments reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
ARK & TLK Investments sold 10,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $40.4K.
ARK & TLK Investments first reported a position in Checkpoint Therapeutics in Q4 2023 and held it in 6 quarters.
ARK & TLK Investments's Checkpoint Therapeutics position peaked at $40.4K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on ARK & TLK Investments's 13F filing for Q2 2025, filed 13 Aug 2025.